Antonio Giordani

1.2k total citations
37 papers, 900 citations indexed

About

Antonio Giordani is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Antonio Giordani has authored 37 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Pharmacology. Recurrent topics in Antonio Giordani's work include Inflammatory mediators and NSAID effects (12 papers), Chemical Synthesis and Analysis (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Antonio Giordani is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Chemical Synthesis and Analysis (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Antonio Giordani collaborates with scholars based in Italy, South Korea and New Zealand. Antonio Giordani's co-authors include Maurizio Anzini, Andrea Cappelli, Mariangela Biava, Francesco Makovec, Gianfranco Caselli, Salvatore Vomero, Carla Ghelardini, Lidia Sautebin, Antonietta Rossi and Giovanna Poce and has published in prestigious journals such as Journal of Medicinal Chemistry, Biomacromolecules and European Journal of Medicinal Chemistry.

In The Last Decade

Antonio Giordani

37 papers receiving 880 citations

Peers

Antonio Giordani
Li-Fang Yu China
Małgorzata Zygmunt Poland
Andrew Pike United Kingdom
Aurelio Orjales Spain
Catia Cornacchia Italy
Matthias Lehr Germany
Benjamin E. Blass United States
Anthony F. Kreft United States
Daniel Chavarria Portugal
Jana Janočková Czechia
Li-Fang Yu China
Antonio Giordani
Citations per year, relative to Antonio Giordani Antonio Giordani (= 1×) peers Li-Fang Yu

Countries citing papers authored by Antonio Giordani

Since Specialization
Citations

This map shows the geographic impact of Antonio Giordani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Giordani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Giordani more than expected).

Fields of papers citing papers by Antonio Giordani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Giordani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Giordani. The network helps show where Antonio Giordani may publish in the future.

Co-authorship network of co-authors of Antonio Giordani

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Giordani. A scholar is included among the top collaborators of Antonio Giordani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Giordani. Antonio Giordani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Consalvi, Sara, Giovanna Poce, Carla Ghelardini, et al.. (2020). Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis. European Journal of Medicinal Chemistry. 210. 112983–112983. 4 indexed citations
2.
Cheleschi, Sara, V. Calamia, M. Fernández-Moreno, et al.. (2018). In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis. International Immunopharmacology. 64. 86–100. 12 indexed citations
3.
Mancini, Alessandra, Angela Di Capua, Loretta Castelli, et al.. (2016). Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents. European Journal of Medicinal Chemistry. 126. 614–630. 14 indexed citations
4.
Capua, Angela Di, Claudia Sticozzi, Simone Brogi, et al.. (2015). Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity. European Journal of Medicinal Chemistry. 109. 99–106. 31 indexed citations
5.
Rosso, Natalia, V. Marin, Antonio Giordani, et al.. (2015). The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular). Current Medicinal Chemistry. 22(25). 2954–2971. 9 indexed citations
6.
Cheleschi, Sara, Nicola Antonio Pascarelli, Giuseppe Valacchi, et al.. (2015). Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β. International Immunopharmacology. 28(1). 794–801. 28 indexed citations
7.
Sticozzi, Claudia, Giuseppe Belmonte, Franco Cervellati, et al.. (2013). Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes. European Journal of Pharmaceutical Sciences. 49(2). 133–141. 20 indexed citations
8.
9.
Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, et al.. (2013). Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. Bioorganic & Medicinal Chemistry. 22(2). 772–786. 21 indexed citations
10.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2013). Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds. European Journal of Medicinal Chemistry. 63. 85–94. 28 indexed citations
11.
Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, et al.. (2012). Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme. European Journal of Medicinal Chemistry. 58. 287–298. 15 indexed citations
12.
Biava, Mariangela, Giovanna Poce, Claudio Battilocchio, et al.. (2011). Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents. Current Medicinal Chemistry. 18(10). 1540–1554. 10 indexed citations
13.
Lanza, Marco, et al.. (2011). Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. Journal of Pain Research. 4. 111–111. 43 indexed citations
14.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2010). Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4‐c]quinolin‐1‐one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors. ChemMedChem. 5(5). 739–748. 26 indexed citations
15.
Rienzo, Francesca De, Puneet Saxena, Gianfranco Caselli, et al.. (2009). Progress Towards the Identification of New Aggrecanase Inhibitors. Current Medicinal Chemistry. 16(19). 2395–2415. 19 indexed citations
16.
Giordani, Antonio, et al.. (1998). 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. Bioorganic & Medicinal Chemistry Letters. 8(20). 2907–2912. 22 indexed citations
17.
Giordani, Antonio, Michela Cini, M. Marconi, et al.. (1996). Benzoylalanine Analogues as Inhibitors of Rat Brain Kynureninase and Kynurenine 3-Hydroxylase. Advances in experimental medicine and biology. 398. 499–505. 3 indexed citations
18.
Giordani, Antonio, et al.. (1996). Enantiospecific Synthesis and in vitro Activity of Selective Inhibitors of Rat Brain Kynureninase and Kynurenine-3-Hydroxylase. Advances in experimental medicine and biology. 398. 531–534. 14 indexed citations
19.
Cozzi, Paolo, Antonio Giordani, Maria Menichincheri, et al.. (1994). Agents Combining Thromboxane Receptor Antagonism with Thromboxane Synthase Inhibition: [[[2-(1H-Imidazol-1-yl)ethylidene]amino]oxy]alkanoic Acids. Journal of Medicinal Chemistry. 37(21). 3588–3604. 23 indexed citations
20.
Vecchietti, Vittorio, et al.. (1991). (2S)-1-(Arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective .kappa. opioid analgesics. Journal of Medicinal Chemistry. 34(1). 397–403. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li-Fang Yu Breakdown of academic impact, for papers by Małgorzata Zygmunt Breakdown of academic impact, for papers by Andrew Pike Breakdown of academic impact, for papers by Aurelio Orjales Breakdown of academic impact, for papers by Catia Cornacchia Breakdown of academic impact, for papers by Matthias Lehr Breakdown of academic impact, for papers by Benjamin E. Blass Breakdown of academic impact, for papers by Anthony F. Kreft Breakdown of academic impact, for papers by Daniel Chavarria Breakdown of academic impact, for papers by Jana Janočková
Rankless by CCL
2026